Home / Research Articles Hub / Cancer pharmacoinformatics: Databases and analytic...
🧬 Medicine & Biology PubMed

Cancer pharmacoinformatics: Databases and analytical tools.

📅 Published: September 19, 2024 👤 Kamble Pradnya, Nagar Prinsa R, Bhakhar Kaushikkumar A et al. 📖 Functional & integrative genomics
AI-Generated Summary

Cancer is a subject of extensive investigation, and the utilization of omics technology has resulted in the generation of substantial volumes of big data in cancer research. Multiple software tools are associated with oncoinformatics research.

⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.

Key Findings
  • 1 Numerous databases are being developed to manage and organize this data effectively.
  • 2 These databases encompass various domains such as genomics, transcriptomics, proteomics, metabolomics, immunology, and drug discovery.
  • 3 The application of computational tools into various core components of pharmaceutical sciences constitutes "Pharmacoinformatics", an emerging paradigm in rational drug discovery.
Why It Matters

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source:

Read Full Paper at PubMed
More Medicine & Biology Papers ← Back to Hub 📚 Learning Hub